Stc.unm

Other

Reema Zeineldin

Gabriel P Lopez

Menake E Piyasena

Sireesha Chemburu

In one embodiment, the invention provides a new design of nanocarrier compositions that release their therapeutic load specifically at intraperitoneal cancers' site. These nanocarriers are administered intraperitoneally and comprise a plurality of porous nanoparticulates that (a) are loaded with one or more pharmaceutically-active agents alone or in combination with imaging agents thus providing a theranostic value and (b) that are encapsulated by and that support a lipid bilayer which is disrupted upon contact with a reactive oxygen species generated within the environment of the cancer. In other embodiments, the invention provides methods of treatment and pharmaceutical compositions comprising nanocarriers as described herein.

Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers

The invention relates to lipid bilayer coated beads and methods of using those beads in delivery systems, in immunoassays, in analytical assays and the like.

Detection and delivery systems utilizing supported lipid bilayers

The invention relates to lipid bilayer coated beads and methods of using those beads in immunoassays, in analytical assay and the like.

Growing community of inventors

Albuquerque, NM, United States of America

Reema Zeineldin